Name | 10-butan-2-yl-7-(2-methylpropyl)-4-propan-2-yl-15,16-dithia-3,6,9,12,18-pentazabicyclo[11.4.2]nonadecane-2,5,8,11,19-pentone |
---|---|
Synonyms |
Malformins
MALFORMIN A Cyclic(D-cysteinyl-D-cysteinyl-L-valyl-D-leucyl-L-isoleucyl)cyclic(1-2)-disulfide cyclo-D-cysteinyl-D-cysteinyl-L-valyl-D-leucyl-L-isoleucyl AmbotzLS-1149 Malformin A1 4-(butan-2-yl)-7-(2-methylpropyl)-10-(propan-2-yl)-15,16-dithia-2,5,8,11,19-pentaazabicyclo[11.4.2]nonadecane-3,6,9,12,18-pentone |
Description | Malformin A1, a cyclic pentapeptide isolated from Aspergillus niger, possess a range of bioactive properties including antibacterial activity. Malformin A1 shows potent cytotoxic activities on human colorectal cancer cells. Malformin A1 induces apoptosis by activating PARP, caspase 3, -7, and -9[1]. |
---|---|
Related Catalog | |
References |
Density | 1.123 g/cm3 |
---|---|
Boiling Point | 921ºC at 760 mmHg |
Molecular Formula | C23H39N5O5S2 |
Molecular Weight | 529.71600 |
Flash Point | 510.8ºC |
Exact Mass | 529.23900 |
PSA | 196.10000 |
LogP | 2.21120 |
Index of Refraction | 1.497 |
Storage condition | -20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Hazard Codes | T+ |
---|---|
Risk Phrases | 23/24/25 |
Safety Phrases | 36/37/39-45 |